Proinflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) play an important role in the blood-brain barrier breakdown present in several neurological diseases including multiple sclerosis and AIDS. However, the specific effects of these cytokines on central nervous system-derived endothelial cells (CNS-EC) is not fully understood. In this study the effects of TNF-α and IL-6 were tested on different permeability mechanisms of CNS-EC.
Methods
Central nervous system endothelial cells were isolated from human brain and retina and cultured in vitro in a transwell system. Fluid-phase endocytosis and transcytosis, absorptive-mediated endocytosis, and ammonia diffusion were measured with specific methods. Endothelial cells were studied with electron microscopy for the ultrastructural effects of cytokine stimulation.
Results
Fluid-phase endocytosis and transcytosis were significantly increased by TNF-α and IL-6. This effect was dose dependent and reversible. The ammonia diffusion rate was also significantly increased by TNF-α. Absorptive-mediated endocytosis was not enhanced by TNF-α. Ultrastructural analysis of cytokine-treated CNS-EC confirmed the alterations in permeability showing an increase in endocytotic activity and a decrease in tight junctions.
Conclusions
The proinflammatory cytokines IL-6 and TNF-α induce specific changes in the morphology and permeability of CNS-EC. These alterations can be important in many diseases characterized by increased cytokine production.
PowerC, KongPA, CrawfordTO, WesselinghS, GlassJD, McArthurJC, TrappBD.Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol1993;34:339–50.
2.
PetitoCK, CashKS.Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol1992;32(5):658–66.
3.
RhodesRH.Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol1991;50(2):171–83.
4.
McLeanBN, ZemanAZJ, BarnesD, ThompsonEJ.Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis. J Neurol Neurosurg Psychiatry1993;56(4):356–60.
5.
SharieffMK, ThompsonEJ.In vivo relationship of tumor necrosis factor to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol1992;38:27–34.
6.
AchimCL, HeyesMP, WileyCA.Quantitation of immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest1993;91:2769–75.
7.
WesselinghSL, PowerC, GlassJD, TyorWR, McArthurJC, FarberJM, GriffinJW, GriffinDE.Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol1993;33:576–82.
8.
SteffenM, ReineckerHC, PetersenJ, DoehnC, PfluegerI, VossA, RaedlerA.Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes, and alveolar macrophages from HIV-infected patients. Clin Exp Immunol1993;91:30–6.
9.
SharieffMK, HentgesR.Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med1991; 15:325(7):467–72.
HartungHP, JungS, StollG, ZielasekJ, SchmidtB, ArchelosJJ, ToykaKV.Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol1992;40:197–210.
12.
PoberJS.Cytokine-mediated activation of vascular endothelium. Am J Pathol1988;133(3):426–33.
13.
CamussiG, TurelloE, BussolinoF, BaglioniC.Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol1991;96:84–91.
14.
HofmanFM, WrightAD, DohadwalaMM, Wong-StaalF, WalkerSM.Exogenous tat protein activates human endothelial cells. Blood1993;82:2774–80.
HofmanFM, DohadwalaMM, WrightAD, HintonDR, WalkerSM.Exogenous tat protein activates nervous system-derived endothelial cells. J Neuroimmunol1994;54:19–28.
18.
JaffeEA, NachmanRL, BeckerDG, MinickCR.Culture of human endothelial cells derived from umbilical veins. J Clin Invest1973;52:2745–51.
19.
SimionescuM, GhitescuL, FixmanA, SimionescuN.How plasma macromolecules cross the endothelium. News in Physiological Sciences1987;2:97–100.
20.
PardridgeWM, BoadsRJ.Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEBS Lett1991;288:30–2.
21.
PardridgeWM, TrigueroD, BuciakJL, YangJ.Evaluation of cationized rat-albumin as a potential blood-brain barrier drug transport vector. J Pharmacol Exp Ther1990;255:893–9.
22.
ReeseT, KarnovskyMJ.Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol1967;34:207–17.
23.
ConnellCJ, MercerKL.Freeze-fracture appearance of the capillary endothelium in the cerebral cortex of mouse brain. Amer J Anat1974.;140:595–600.
24.
PotvinM, FinlaysonMH, HincheyEJ, LoughJO, GoreskyCA.Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab Invest1984;55(5):560–4.
25.
KatoM, HughesRD, KeaysRT, WilliamsR.Electron micro-scopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology1992;15:1060–6.
26.
SchaferDF.The blood-brain barrier in acute liver failure. In: KleinbergerG, FerenciP, RiedererP, ThalerH, eds. Advances in hepatic encephalopathy and urea cycle diseases. Vienna: Karger; 1984;232–9.
27.
WestergardE, Van DeursB, BondstedHE.Increased vesicular transfer of horseradish peroxidase across cerebral endothelium, evoked by acute hypertension. Acta Neuropathol (Berl)1977;37:141–52.
28.
ShiversR, EdmondsC, Del MaestroR.Microvascular permeability in induced astrocytoma and peritumor neuropil of rat brain. Acta Neuropathol1984;64; 192–202.
29.
WellerR, FoyM, CoxS.The development and ultrastructure of the microvasculature in malignant gliomas. Neuropathol Appl Neurobiol1977;3:307–22.
30.
PerssonL, HanssonHA.Reversible blood-brain barrier dysfunction to peroxidase after a small stab wound in the rat cerebral cortex. Acta Neuropathol (Berl)1976;35:333–42.
31.
PovlishockJT, BeckerDP, SullivanHG, MillerJD.Vascular permeability alterations to horseradish peroxidase in experimental brain injury. Brain Res1978;153; 222–31.
32.
StolpenAH, GuinonEC, FiersW, PoberJS.Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol1986;123:16–23.
33.
LangelerEG, FiersW, Van HinsbergVWM. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers. Arterioscler Thromb1991;11:872–81.
34.
SaukkonenK, SandeS, CioffeC, WolpeS, SherryB, CeramiA, TuomanenE.The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med1990;171:439–49.
KimKS, WassCA, CrossAS, OpalSM.Modulation of blood-brain barrier permeability by tumor necrosis factor in the rat. Lymphokine Cytokine Res1992;11:293–8.
37.
RoyallJA, BerkowRL, BeckmanJS, CunninghamMK, MatalonS, FreemanBA.Tumor necrosis factor and interleukin-1 increase vascular endothelial permeability. Am J Physiol1989;257:L399–L410.
38.
GoldblumSE, SunWL.TNF augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol1990;258:257–67.
39.
GibbsLS, LaiL, MalikAB.Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol1990;145:496–500.
40.
PekalaP, MarlowM, HeuvelmanD, ConnollyD.Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-but not by insulin. J Biol Chem1990;265(30):18051–4.
41.
MoserR, SchleiffenbaumB, GroscurthP, FehrJ.Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote neutrophil passage. J Clin Invest1989;82:444–55.
42.
BeynonHLC, HaskardDO, DaviesKA, HaroutunianR, WalportMJ.Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol1993;91:314–9.
43.
GaffneyAB, KeenanAK.Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1α/β, tumor necrosis factor-α and interferon-γ. Immunopharmacology1993;25:1–9.
44.
PardridgeWM.Peptide drug delivery to the brain. New York: Raven Press; 1991;149–218.
45.
KleinNJ, ShennanGI, HeydermanRS, LevinM.Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin, and neutrophils. J Cell Sci1992;102:821–31.
46.
LongD.Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg1970; 32:127–44.
47.
GreigN, JonesH, LavanaghJ.Blood-brain barrier integrity and host response in experimental metastatic brain tumors. Clin Exp Metastasis1983;1:229–46.
48.
CoxD, PilkingtonG, LantosP.The fine structure of blood vessels in ethylnitrosourea-induced tumors of the rat nervous system. With special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol1976;57:419–30.
49.
HiranoA, MatsuiT.Vascular structures in brain tumors. Hum Pathol1975;6:611–21.
50.
WaggenerJ, BeggsJ.Vasculature of neural neoplasms. Adv Neurol1976;15:27–49.
51.
LossinskyAS, VorbrodtAW, WisniewskiHM.Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol1995;24:795–806.
